Preclinical evaluation of 68Ga-MAA from commercial available 99mTc-MAA kit
Authors
Abstract:
99mTc-Macroaggregated Albumin (99mTc-MAA) has been used as a perfusion agent. This study described development of the 68Ga-MAA via commercially available kits from Pars-Isotopes Company as a 99mTc-MAA kit. 68Ge/68Ga generator was eluted with suprapure HCl (0.6 M, 6 mL) in 0.5 mL fractions. The two fractions with the highest 68GaCl3 activity were generally used for labeling purposes. After labeling, the final product was centrifuged 2 times to purify the solution. Five rats were sacrificed at each exact time interval (from 15 minutes to 2 hours post injection) and the percentage of injected dose per gram (%ID/g) of each organ was measured by direct counting from 11 harvested organs of rats. The RTLC showed that labeling yields before centrifuges were 90% and 95% for Pars-Isotopes and GE kits, respectively and after centrifuges, they became 100%. The microscopic size examination showed a shift in the particle sizes post centrifuges and the biodistribution data revealed the efficiency and benefits of centrifuges in terms of preventing the of liver and bone marrow uptakes especially for Pars-Isotopes kits. Our results showed that after centrifuges of the final product, the lung uptakes increased from 89% to more than 97% of %ID/g after 5 min post injections. The whole procedure took less than 25 min from elution to the final product. Since 99mTc-MAA remained longer than 68Ga-MAA in the lung and 68Ga-MAA showed better image qualities, using 68Ga-MAA is recommended.
similar resources
Preclinical Evaluation of 68Ga-MAA from Commercial Available 99mTc-MAA Kit
99mTc-Macroaggregated Albumin (99mTc-MAA) has been used as a perfusion agent. This study described development of the 68Ga-MAA via commercially available kits from Pars-Isotopes Company as a 99mTc-MAA kit. 68Ge/68Ga generator was eluted with suprapure HCl (0.6 M, 6 mL) in 0.5 mL fractions. The two fractions with the highest 68GaCl3 activity were generally used for labeling purposes. After label...
full textClinical Evaluation of a New 99mTc-MAA Kit for Lung Scanning
Lung scanning has been recognized as a clinically useful technique for portraying macroscopic pulmonary perfusion defects since it was first reported by Wagner in 1964 (1 ). A number of radiopharmaceuticals have been proposed to assess pulmonary perfusion. Although 1 3 1 I imposes many limitations as a radiotagging agent, the use of iodinated macroaggregated albumin (I-MAA) has received wide ac...
full textLyophilized Kit for the Preparation of the PET Perfusion Agent [68Ga]-MAA
Rapid developments in the field of medical imaging have opened new avenues for the use of positron emitting labeled microparticles. The radioisotope used in our research was (68)Ga, which is easy to obtain from a generator and has good nuclear properties for PET imaging. Methods. Commercially available macroaggregated albumin (MAA) microparticles were suspended in sterile saline, centrifuged to...
full textEvaluation of the dose received by women worker in the lung scan centers use 99mTC-MAA by experimental and simulation
One of the most important groups that can be exposed to nuclear radiation is pregnant women and their fetus. This group of people can be technicians at nuclear centers located in the patients undergoing treatment or nuclear medicine diagnostic centers. The purpose of the paper is to determine the rate of doses received by female technicians who are indirectly in the vicinity of nuclear radiatio...
full textAbsent pulmonary uptake on 99mTc MAA perfusion lung scan due to severe right-to-left shunt.
c 5 XTRAPULMONARY accumulation of Tc macroaggregated albumin (MAA) is rarely een on perfusion lung scan, and has been reported n less than 4% of a study population of nearly 380 atients.1 It occurs when the agent bypasses the ungs due to a right-to-left (R-L) cardiac or pulonary shunt, when it is shunted to the portal vein efore reaching the right atrium and ventricle of he heart, and when the ...
full textMy Resources
Journal title
volume 16 issue 4
pages 1415- 1423
publication date 2017-11-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023